Bernadette Brzezicha - EPO GmbH, Germany, Berlin

基本信息

浏览量：8

职业迁徙

个人简介

Bernadette Brzezicha currently works at the Patient derived tumor models, EPO GmbH, Germany, Berlin. Their current project is 'Immunoncology in preclinical models'.

研究兴趣

论文共 55 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Establishment and Thorough Characterization of Xenograft (PDX) Models Derived from Patients with Pancreatic Cancer for Molecular Analyses and Chemosensitivity Testing

Diana Behrens,Ulrike Pfohl,Theresia Conrad,Michael Becker,Bernadette Brzezicha,Britta Buettner,Silvia Wagner,Cora Hallas,Rita Lawlor,Vladimir Khazak,Michael Linnebacher,Thomas Wartmann,Iduna Fichtner,Jens Hoffmann,Mathias Dahlmann,Wolfgang Walther

Cancersno. 24 (2023): 5753-5753

引用0浏览0WOS引用

Abstract PO-070: New Patient-Derived Head and Neck Cancer Xenograft (PDX) Panel for Drug Development, Immuno-Oncology and Translational Research

Bernadette Brzezicha,Theresia Conrad,Maria Stecklum,Michael Becker,Konrad Klinghammer,Jens Hoffmann

Clinical Cancer Researchno. 18_Supplement (2023)

引用0浏览0引用

Abstract 5204: Preclinical Models for Translational Immuno-Oncology Research: Rare Patient-Derived Xenografts on Humanized Mice

Maria Stecklum,Annika Wulf-Goldenberg,Bernadette Brzezicha,Wolfgang Walther,Jens Hoffmann

Cancer Researchno. 7_Supplement (2023): 5204-5204

引用0浏览0引用

Abstract A005: Preclinical Evaluation of Novel Immune Cell Therapies, Check Point Inhibitors, and Immune Cell Engagers in Humanized Mouse Models

Maria Stecklum,Annika Wulf‐Goldenberg,Bernadette Brzezicha,Joshua Alcaniz, G. Smits,Wolfgang Walther,Jens Hoffmann

Molecular cancer therapeuticsno. 12_Supplement (2023): A005-A005

引用0浏览0引用

Abstract 4674: Patient-derived Xenograft (PDX) and Corresponding Cell Line Models from Glioblastoma for Drug Development, Immuno-Oncology and Translational Research

Joshua Alcaniz,Lars Winkler,Maria Stecklum,Hagen Wieland,Antje Siegert,Michael Becker,Bernadette Brzezicha,Wolfgang Walther,Jens Hoffmann

CANCER RESEARCHno. 7 (2023)

引用0浏览0引用

Abstract A081: Patient-derived Xenograft Models from Hematological Malignancies for Preclinical Drug Development and Biomarker Research

Antje Siegert,Bernadette Brzezicha,Stephan Fuhrmann,Martin Janz, Clemens A. Schmitt,Ulrich Keller, Christian Rupp,Wolfgang Walther,Jens Hoffmann

Molecular cancer therapeuticsno. 12_Supplement (2023): A081-A081

引用0浏览0引用

Humanized Mouse Models for Preclinical Evaluation of Novel Immune Therapies, Checkpoint Inhibitors and Immune Cell Engagers

Maria Stecklum,Annika Wulf-Goldenberg,Bernadette Brzezicha,Wolfgang Walther,Jens Hoffmann

European journal of cancer（2022）

引用0浏览0引用

New Patient Derived Lymphoma Xenograft (PDX) Panel for Drug Development, Immuno-Oncology and Translational Research

Bernadette Brzezicha,Theresia Conrad,Maria Stecklum,Michael Becker,Konrad Klinghammer,Jens Hoffmann

European journal of cancer（2022）

引用0浏览0引用

Activated SUMOylation restricts MHC class I antigen presentation to confer immune evasion in cancer

Uta M. Demel, Marlitt Boeger,Schayan Yousefian,Corinna Grunert,Le Zhang,Paul W. Hotz,Adrian Gottschlich, Hazal Koese,Konstandina Isaakidis,Dominik Vonficht,Florian Gruenschlaeger,Elena Rohleder,Kristina Wagner, Judith Doenig, Veronika Igl,Bernadette Brzezicha,Francis Baumgartner,Stefan Habringer, Jens Loeber,Bjoern Chapuy,Carl Weidinger, Sebastian Kobold,Simon Haas,Antonia B. Busse,Stefan Mueller,Matthias Wirth,Markus Schick,Ulrich Keller

JOURNAL OF CLINICAL INVESTIGATION（2022）

引用17浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn